Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
L37 Ventures is a private investment firm that describes itself as a hybrid venture capital, private equity, and alternative assets manager. The firm works with founders and executive teams to help build and scale companies, and it appears to invest across multiple sectors rather than operating as a therapeutics developer, pharmaceutical company, or healthcare services operator. Publicly available descriptions emphasize company-building support, capital formation, talent access, and strategic frameworks rather than an internal drug pipeline. Although some of its partners have healthcare and life sciences backgrounds and the firm has invested in companies that may touch health-related sectors, L37 Ventures itself is best classified as an investment firm rather than a life sciences company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on L37 Ventures.